APOE and Alzheimer disease: While these analyses suggest that plasma levels of APOE are a good marker of pre-clinical AD, it is possible that these results may be influenced by effects of APOE genotype, which modifies AD risk [22]–[26] and may also influence cognitive performance in non-demented individuals [27]–[30].